BioMark Records First Revenues
Press Release BIOMARK RECORDS FIRST REVENUES – December 4 2014-F (PDF) ———————————————
Dr. Safieddin Safavi-Naeini Joins Biomark Scientific Advisory Team
Dr. SAFIEDDIN SAFAVI-NAEINI JOINS BIOMARK SCIENTIFIC ADVISORY TEAM (PDF) ———————————————
Wolverton Securities advisor believes in biotechnology
Santo Sandhu, an investment advisor with Wolverton Securities, said he believes the best opportunities right now lie in biotechnology. That has led him to BioMark Diagnostics Inc., a Richmond B.C. company that is developing a cancer diagnostic system, using a known drug, which has already been approved by the U.S. Federal Drug Administration and Health […]
BioMark Lists on Frankfurt Stock Exchange
Press Release BIOMARK LISTS ON FRANKFURT STOCK EXCHANGE – November 26, 2014 (PDF) ———————————————
BioMark Receives the Commercialization Support for Business (CSB) Stream 1 Program
Press Release BioMark Receives the Commercialization Support for Business (CSB) Stream 1 Program (PDF) ————————————————-
Dr. JOHN YOO JOINS BIOMARK ADVISORY TEAM
Vancouver, British Columbia – (November 17th, 2014) –BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) is pleased to announce that it has appointed Dr. John Yoo to its clinical advisory team. Dr. Yoo is the Professor and Chair, City-Wide Chief, Department of Otolaryngology-Head and Neck Surgery and Professor in the Department of Oncology at the Schulich School […]
Dr. John Yoo Joins BioMark Advisory Team
Dr. JOHN YOO JOINS BIOMARK ADVISORY TEAM – November 17, 2014 (PDF) ————————————————-
BioMark Diagnostics, Inc. to present at the inaugural equities.com Small-Cap Stars Conference at the NASDAQ MarketSite on December 18, 2014
NASDAQ MarketSite (PDF) ———————————————
BioMark Announces Appointment of Bill Good
BIOMARK_ANNOUNCES_APPOINTMENT_OF_BILL_GOOD (PDF) ————————————————-
BioMark Approved Listing and Commences Trading on the CSE
Biomark_Approved_for_Listing_and_Commences_Trading_on_the_CSE (PDF) ————————————————-